Stellarex BTK 0.014" Drug-Coated Angioplasty Balloon

The Clear DCB Choice

Featuring EnduraCoat Technology

Learn More +

Choose safety, durability and predictability for treatment of below-the-knee lesions

0.014″ DCB is not approved for distribution, sale or use in the USA.
Availability of this product may vary by country.

The Stellarex Difference

Stellarex’s unique coating composition, EnduraCoat Technology, combines amorphous and small-to-large crystalline paclitaxel with polyethylene glycol (PEG) excipient. The result is efficient drug transfer, effective tissue residency, high coating durability and minimal particulate loss.

about the coating +

Choose Safety

Particulate loss is associated with an increased risk of downstream embolization. In bench tests, Stellarex demonstrated significantly less particulate loss than its competitors.

compare particulate +
Stellarex DCB Ballon

See more Stellarex clinical evidence

download brochure +